ResearcherTokai UniversityNo recent work listed

Satoshi Owada

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5054801981. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 3

Evaluation of Erastin as a Therapeutic Agent Under Hypoxic Conditions in Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.15424 ↗
Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer. Co-author DOI 10.1371/journal.pone.0198219 ↗
An Adaptation System to Avoid Apoptosis via Autophagy Under Hypoxic Conditions in Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.11902 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Masayuki Tatemichi · 2 shared papers, 2017–2021 · strength 0.24
- Paper Evaluation of Erastin as a Therapeutic Agent Under Hypoxic Conditions in Pancreatic Cancer Cells. DOI 10.21873/anticanres.15424 ↗
- Paper An Adaptation System to Avoid Apoptosis via Autophagy Under Hypoxic Conditions in Pancreatic Cancer Cells. DOI 10.21873/anticanres.11902 ↗
Rumi Fujioka · 1 shared paper, 2018 · strength 0.08
- Paper Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with ge… DOI 10.1371/journal.pone.0198219 ↗
Hiroyasu Esumi · 1 shared paper, 2018 · strength 0.08
- Paper Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with ge… DOI 10.1371/journal.pone.0198219 ↗
Masafumi Ikeda · 1 shared paper, 2018 · strength 0.08
- Paper Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with ge… DOI 10.1371/journal.pone.0198219 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.